Literature DB >> 13130150

TNF-alpha blockade for herniated intervertebral disc-induced sciatica: a way forward at last?

R G Cooper, A J Freemont.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 13130150     DOI： 10.1093/rheumatology/keh013

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  5 in total

1.  Radiculopathy associated with disc herniation.

Authors:  P Goupille; D Mulleman; J-P Valat
Journal:  Ann Rheum Dis       Date:  2006-02       Impact factor: 19.103

Review 2.  A systematic review and meta-analysis of biological treatments targeting tumour necrosis factor α for sciatica.

Authors:  Nefyn H Williams; Ruth Lewis; Nafees Ud Din; Hosam E Matar; Deborah Fitzsimmons; Ceri J Phillips; Alex Sutton; Kim Burton; Maggie Hendry; Sadia Nafees; Clare Wilkinson
Journal:  Eur Spine J       Date:  2013-03-26       Impact factor: 3.134

3.  The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration.

Authors:  Christine Lyn Le Maitre; Anthony J Freemont; Judith Alison Hoyland
Journal:  Arthritis Res Ther       Date:  2005-04-01       Impact factor: 5.156

4.  Lessons learnt from a discontinued randomised controlled trial: adalimumab injection compared with placebo for patients receiving physiotherapy treatment for sciatica (Subcutaneous Injection of Adalimumab Trial compared with Control: SCIATiC).

Authors:  Nefyn H Williams; Alison Jenkins; Nia Goulden; Zoe Hoare; Dyfrig A Hughes; Eifiona Wood; Nadine E Foster; David Walsh; Dawn Carnes; Valerie Sparkes; Elaine M Hay; John Isaacs; Kika Konstantinou; Dylan Morrissey; Jaro Karppinen; Stephane Genevay; Clare Wilkinson
Journal:  Trials       Date:  2018-07-31       Impact factor: 2.279

5.  Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1beta and TNFalpha expression profile.

Authors:  Christine Lyn Le Maitre; Judith Alison Hoyland; Anthony J Freemont
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.